Notice on Extraordinary Shareholders’ Meeting of Latvijas

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Notice on Extraordinary Shareholders’ Meeting of Latvijas Jūras medicīnas centrs JSC.

Latvia, 2014-07-31 14:37 CEST (GLOBE NEWSWIRE) -- Notice on Extraordinary Shareholders’ Meeting of Latvijas Jūras medicīnas centrs JSC that is Sche            duled to take place on September 4, 2014.

The Management Board of Latvijas Jūras medicīnas centrs JSC hereby makes an announcement on extraordinary meeting of shareholders on September 4, 2014 at 17.00, in Riga, Patversmes iela 23.

 Agenda:

1.       Election of the Auditor.

2.      Amendments to the Articles of Association and the denomination of the nominal value of shares from lats to euro.

 Registration of the shareholders on the day of the extraordinary meeting September 4, 2014 from 16.15 until 17.00 at the place of holding of the general meeting.

The record date for fixation of the shareholders’ list for participation of shareholders in the extraordinary meeting is August 27, 2014. Only persons that are shareholders on the record date are entitled to participate in the shareholders’ general meeting.

The shareholders can participate in the general meeting in person or through their representatives. Upon registration shareholders must present their identity document, whereas authorized representatives shall in addition present properly completed authorization. The authorization form is available on the website www.ljmc.lv and in the office at Riga, Patversmes iela 23.

 Shareholders may exercise their rights in accordance with the procedure and within the scope specified in Section 274 (2) and  276 (3) of the Commercial Law, Section 54. 2 (1), (2) of the Financial Instrument Market Law within 7 days since the release of this notice and on the day of the shareholders’ meeting, whereas the rights in accordance with the procedure and within the scope specified in Section 276 (4) and Section 283 (1) of the Commercial Law can be exercised at least 7 days before the shareholders' general meeting and on the day of the shareholders’ general meeting. Detailed information on the above mentioned shareholders’ rights is available on the website of Latvijas Jūras medicīnas centrs JSC www.ljmc.lv .

 The draft resolutions on the issues on the agenda of the general meeting of shareholders are available  for shareholders at the secretary of Latvijas Jūras medicīnas centrs JSC in Riga, Patversmes iela 23 starting from July 31, 2014 at 14.00 until 16.00 o’clock, telephone 67391315, at website of NASDAQ OMX Baltic, in the Central Storage of Regulated Information and on the website of Latvijas Jūras medicīnas centrs JSC www.ljmc.lv .

Latvijas Jūras medicīnas centrs JSC has issued 800,000 shares with voting rights.

 Management Board of the Joint Stock Company “Latvijas Jūras medicīnas centrs”

         Member of Board Juris Imaks 2951249

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lee Enterprises Achieves Major Growth With $16.85 Stock Peak

Updated Category News Views 130

Lee Enterprises Stock Reaches New Heights Lee Enterprises, Incorporated (LEE) has recently made headlines as its stock hit a remarkable 52-week high, trading at $16.85. This surge is indicative of a 61.48% increase over the past year, capturing the attention of both investors and market analysts. Many are watching closely as the company continues to outperform...

Continue Reading
Exciting Upcoming Events by TurfMutt Foundation for Pet Lovers

Updated Category News Views 164

TurfMutt Foundation's Signature Events Announced for 2025 The TurfMutt Foundation is set to bring joy and bring together pet lovers and their furry friends at the upcoming Equip Exposition in 2025. This renowned foundation, known for its commitment to promoting green spaces and animal rescue, is excited to announce its signature events that promise to engage and inspire....

Continue Reading
Significant Advances in PNH Treatment with Novartis' Fabhalta

Updated Category News Views 171

Revolutionizing PNH Treatment with Fabhalta Novartis has showcased exciting developments in the realm of paroxysmal nocturnal hemoglobinuria (PNH) treatment through its innovative oral medication, Fabhalta. The recent Phase IIIB APPULSE-PNH study revealed that adults with PNH, who transitioned to Fabhalta, experienced a notable uptick in hemoglobin (Hb) levels, averaging...

Continue Reading
Current Net Asset Value Overview for Hargreave Hale AIM VCT

Updated Category News Views 146

Understanding the Latest NAV Announcement As of November 28, 2025, Hargreave Hale AIM VCT PLC has reported its unaudited Net Asset Value (NAV). This financial metric is crucial for investors, as it gives a clear indication of the company's performance and value. The NAV per ordinary share of 1p stands at an impressive 35.27 pence, speaking volumes about the company’s...

Continue Reading
Timbercreek Financial Announces Monthly Dividend for Shareholders

Updated Category News Views 243

Timbercreek Financial Announces Exciting Dividend Update Timbercreek Financial (TSX: TF) has made a positive announcement regarding its dividends. Recently, the Company declared a monthly cash dividend of $0.0575 for every common share, showing their commitment to returning value to their shareholders. Dividend Payment Details This dividend is set to be paid on a...

Continue Reading